EGF and pancreatic adenocarcinoma: In agreement with this possibility, Deltazinone 1 required a much higher concentration (20 μM) to modestly inhibit EGF-induced S6 phosphorylation in a human pancreatic adenocarcinoma cell line and was ineffective in another pancreatic cancer cell line tested (Papke et al., 2016).